All practice questions

4736 questions

Question 3881Question →

Identify the appropriate ethical doctrine or legal standard that dictates medical decision-making for the following incapacitated individuals.

Click a left item, then click its matching right item

Items

A comatose 68-year-old stroke patient whose daughter references a conversation from two years ago where the patient explicitly rejected artificial life support.
A 34-year-old resident of a group home with severe intellectual disability since birth who requires consent for a necessary surgical procedure.
A John Doe trauma victim with exsanguinating hemorrhage from a ruptured spleen requiring immediate transport to the operating room.
An 80-year-old patient with advanced Alzheimer disease whose legally designated health care agent refuses a feeding tube, while the patient's adult children threaten litigation to force the placement.

Matches

Show answer & explanation

Answer

Match the scenarios based on the patient's prior capacity, presence of legal documents, and clinical urgency: stroke patient matches Substituted judgment standard; group home resident matches Best interest standard; trauma victim matches Emergency implied consent; Alzheimer patient matches Healthcare proxy authority.
Each clinical situation demands a specific ethical and legal framework. The substituted judgment standard uses the patient's known past preferences. The best interest standard is applied when a patient never possessed decision-making capacity. Emergency implied consent is invoked for immediate, life-saving needs in patients lacking capacity and surrogates. Lastly, a designated healthcare proxy holds legal authority that supersedes the demands of other family members.

Step-by-Step Solution

1
Assess for an immediate, life-threatening emergency.
The John Doe trauma patient requires immediate intervention without time to locate a surrogate, invoking emergency implied consent.
Life-saving care cannot be delayed when a surrogate is unavailable.
2
Check for formally appointed surrogate decision-makers.
The 80-year-old patient has a designated healthcare agent, whose authority supersedes the adult children.
A Durable Power of Attorney for Healthcare overrides the statutory family hierarchy.
3
Determine if the patient previously had capacity and expressed relevant wishes.
The 68-year-old stroke patient expressed wishes prior to losing capacity, guiding the daughter via the substituted judgment standard.
Surrogates must attempt to make the decision the patient would have made.
4
Evaluate patients who have never possessed decision-making capacity.
The 34-year-old with lifelong severe intellectual disability falls under the best interest standard.
Because the patient could never formulate or express healthcare values, decisions must maximize overall welfare and minimize harm.

Key Concept

Ethical and legal standards for surrogate decision-making
Question 3882Question →

A public health task force is funding a randomized, non-inferiority clinical trial comparing a novel 3-day oral antibiotic regimen to the standard 7-day oral regimen for uncomplicated urinary tract infections in pregnant patients. The non-inferiority margin (Δ\Delta) is set at a 5% difference in clinical cure rates. The researchers calculated that a sample size of 800 patients (400 per group) is required to achieve 80% statistical power at a one-sided α\alpha level of 0.025, anticipating a maximum 10% dropout rate. Midway through the trial, an independent data monitoring committee notes that the actual dropout rate has exceeded 30% due to patients relocating and missing follow-up appointments. If the researchers continue the trial without modifying the initial enrollment target, which of the following statistical consequences is most likely to occur?

Show answer & explanation

Answer: An increased probability of failing to declare the novel 3-day regimen non-inferior, even if it truly is non-inferior.

Answer

An increased probability of failing to declare the novel 3-day regimen non-inferior, even if it truly is non-inferior.
Statistical power is defined as the probability of correctly rejecting the null hypothesis when it is false, mathematically represented as 1−β1 - \beta. In a non-inferiority trial, the null hypothesis (H0H_0) states that the new treatment is inferior to the standard treatment by at least the pre-specified margin (Δ\Delta). A severe decrease in the effective sample size due to high dropout directly reduces the study's statistical power. Consequently, the Type II error rate (β\beta) increases. This means there is a higher mathematical risk of failing to reject the null hypothesis of inferiority, leading the researchers to incorrectly conclude that they cannot declare the new drug non-inferior, even if it truly is just as effective as the standard regimen.

Step-by-Step Solution

1
Determine the effect of a 30% dropout rate on the trial design.
The effective sample size is significantly smaller than the 800 patients originally calculated.
High attrition means fewer patients complete the trial, providing less data for the final analysis.
2
Correlate the reduced sample size with statistical power.
Statistical power decreases.
Power (1−β1 - \beta) is highly dependent on sample size; as the sample size drops, the variance increases, making it harder to detect a true effect, thus reducing power.
3
Relate the loss of power to error rates.
The Type II error rate (β\beta) increases.
Since Power = 1−β1 - \beta, a decrease in power directly correlates with a mathematical increase in the risk of committing a Type II error.
4
Define Type II error specifically in the context of a non-inferiority trial.
Failing to declare non-inferiority when the drug actually is non-inferior.
In a non-inferiority trial, the null hypothesis (H0H_0) assumes the new treatment is inferior. A Type II error is failing to reject this H0H_0 when it is false (i.e., failing to show non-inferiority when the drug is, in fact, not worse than the standard).

Key Concept

Type II Error (β\beta) and Statistical Power in Non-Inferiority Trials
Question 3883Question →

An armed forces medical induction center is initiating a screening protocol for latent tuberculosis infection among incoming personnel. The protocol utilizes a highly standardized interferon-gamma release assay. Epidemiological surveillance indicates that the true prevalence of latent tuberculosis in this incoming cohort of 5,0005,000 recruits is exactly 4%4\%. The laboratory parameters for this specific assay demonstrate a sensitivity of 90%90\% and a specificity of 98%98\%.

If a recruit from this cohort receives a positive result on this assay, what is the probability that the individual actually has a latent tuberculosis infection? (Enter the value as a percentage rounded to the nearest whole number).

Show answer & explanation

Answer: 65

Answer

65
The question asks for the probability that a patient with a positive test result actually has the disease, which is the definition of Positive Predictive Value (PPV). To calculate PPV, one must account for the prevalence of the disease in the specific cohort being tested. Using a 2x2 contingency table for the population of 5,0005,000 recruits, a prevalence of 4%4\% equates to 200200 individuals with latent tuberculosis and 4,8004,800 healthy individuals. Given a sensitivity of 90%90\%, the assay will correctly identify 180180 of the 200200 diseased individuals (True Positives). Given a specificity of 98%98\%, the false positive rate is 2%2\%; therefore, the assay will incorrectly flag 9696 of the 4,8004,800 healthy individuals (False Positives). The total number of positive test results is the sum of True Positives and False Positives (180+96=276180 + 96 = 276). The PPV is the ratio of True Positives to Total Positives (180/276180 / 276), which equals 0.65210.6521. Converted to a percentage and rounded to the nearest whole number, the correct probability is 65%65\%.

Step-by-Step Solution

1
Determine the true disease status distribution in the cohort.
200 recruits have latent TB; 4,800 do not.
Pre-test probability (prevalence) is required to establish the baseline numbers of true positive and true negative candidates in the population.
2
Calculate the number of True Positives.
180 True Positives.
Sensitivity (90%90\%) dictates the proportion of the 200 diseased individuals who will correctly test positive (200×0.90200 \times 0.90).
3
Calculate the number of False Positives.
96 False Positives.
Specificity is 98%98\%, meaning the false positive rate is 2%2\%. Applying this false positive rate to the 4,800 healthy individuals (4,800×0.024,800 \times 0.02) yields 96.
4
Calculate the Positive Predictive Value (PPV).
65.2%, rounded to 65%.
PPV is the ratio of True Positives to all positive test results: 180/(180+96)=180/276=0.6521180 / (180 + 96) = 180 / 276 = 0.6521.

Key Concept

Positive Predictive Value (PPV) depends heavily on the disease prevalence in the tested population, in addition to the test's sensitivity and specificity.
Question 3884Question →

A prospective cohort study is conducted to evaluate the association between the initiation of a new selective serotonin reuptake inhibitor (SSRI) and the incidence of gastrointestinal (GI) bleeding in older adults. The researchers calculate an unadjusted (crude) Relative Risk (RR) of 1.651.65 (95%95\% CI: 1.20−2.251.20 - 2.25, p<0.01p < 0.01).

To further investigate the relationship, the investigators stratify the analysis based on the concurrent use of nonsteroidal anti-inflammatory drugs (NSAIDs). The stratum-specific results are presented below:

StratumRelative Risk (RR)95% Confidence Interval
Concurrent NSAID use3.103.102.15−4.452.15 - 4.45
No concurrent NSAID use1.081.080.85−1.350.85 - 1.35

Based on these findings, which of the following best describes the role of concurrent NSAID use in this study?

Show answer & explanation

Answer: It acts as an effect modifier

Answer

It acts as an effect modifier
Effect modification (or interaction) occurs when the magnitude of the association between an exposure and an outcome differs depending on the level of a third variable. In this scenario, the crude Relative Risk (RR) for GI bleeding is 1.651.65. However, upon stratification by NSAID use, the stratum-specific RRs differ significantly from each other (3.103.10 vs. 1.081.08). This indicates that concurrent NSAID use modifies the effect of the SSRI on GI bleeding risk. Biologically, this represents a pharmacodynamic synergism, as both SSRIs (by depleting platelet serotonin) and NSAIDs (by inhibiting COX and altering mucosal integrity) independently increase bleeding risk.

Step-by-Step Solution

1
Interpret the unadjusted (crude) Relative Risk.
The crude RR of 1.651.65 suggests a statistically significant overall association between the new SSRI and GI bleeding.
Establishing the baseline measure of association is necessary before evaluating the impact of a third variable.
2
Analyze the stratum-specific Relative Risks.
The RR is 3.103.10 in patients using NSAIDs and 1.081.08 (not statistically significant) in those not using NSAIDs.
Stratification isolates the effect of the exposure within different levels of a third variable to check for confounding and interaction.
3
Compare the stratum-specific RRs to each other and to the crude RR.
The stratum-specific RRs (3.103.10 and 1.081.08) are significantly different from each other and from the crude RR (1.651.65).
When stratum-specific measures differ significantly from each other, the third variable is an effect modifier, indicating a biological interaction.

Key Concept

Effect modification occurs when the magnitude of an effect (e.g., Relative Risk) differs depending on the level of a third variable. It is identified when stratum-specific measures of association are significantly different from one another.
Question 3885Question →

A 52-year-old woman with advanced cervical cancer complicated by bilateral hydronephrosis is admitted to the hospital with intractable pelvic pain and rapidly progressing altered mental status. Over the past three days, her pain became increasingly difficult to control at home, prompting her outpatient physician to double her dose of sustained-release oral morphine. On evaluation, the patient is agitated, picking at her bedsheets, and disoriented to time and place. She exhibits sudden, involuntary jerking movements of her upper and lower extremities. When the physician gently palpates her arm to check her pulse, she screams, complaining that her skin "feels like it is on fire." Vital signs are temperature 37.2°C (99.0°F), pulse 110/min, respirations 16/min, and blood pressure 138/85 mm Hg. Oxygen saturation is 96% on room air. Neurologic examination reveals diffuse hyperalgesia, hyperreflexia, and multifocal myoclonus. Laboratory studies show a serum creatinine level of 3.4 mg/dL (baseline 1.1 mg/dL one month ago). Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Rotate from morphine to intravenous fentanyl

Answer

The most appropriate next step is to rotate from morphine to intravenous fentanyl.
The correct answer addresses the root cause of the patient's symptoms: Opioid-Induced Neurotoxicity (OIN). The patient is experiencing delirium, myoclonus, and paradoxical hyperalgesia due to the accumulation of morphine-3-glucuronide (M3G), a neuroexcitatory metabolite of morphine. This accumulation is secondary to her acute kidney injury (elevated creatinine likely from obstructive uropathy). The definitive treatment for OIN is to discontinue the offending agent and rotate to an opioid that is safe in renal impairment and lacks active neurotoxic metabolites. Intravenous fentanyl is heavily metabolized by the liver into inactive metabolites and is the opioid of choice for patients with severe renal dysfunction.

Step-by-Step Solution

1
Identify the patient's clinical syndrome based on the physical examination and history.
The patient presents with delirium, multifocal myoclonus, and allodynia/hyperalgesia shortly after a significant increase in her morphine dose.
Recognizing this specific triad of symptoms is critical for diagnosing opioid-induced neurotoxicity (OIN).
2
Determine the underlying mechanism causing the syndrome.
The patient has acute kidney injury (creatinine 3.4 mg/dL) due to bilateral hydronephrosis from advanced cervical cancer.
Morphine is metabolized in the liver to morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G), which are renally cleared. In acute kidney injury, the neuroexcitatory metabolite M3G accumulates, leading to OIN.
3
Select the appropriate therapeutic intervention.
The management of OIN involves reducing the opioid dose, providing hydration if appropriate, or rotating to a different opioid.
Because the patient still has severe cancer pain, stopping opioids entirely is inhumane. Rotating to fentanyl or methadone is preferred, as these agents do not produce active neurotoxic metabolites that accumulate in renal failure.

Key Concept

Management of Opioid-Induced Neurotoxicity
Question 3886Question →

An ambulatory surgery center has noted a steady increase in same-day procedure cancellations over the past six months, primarily due to incomplete preoperative medical clearances. The medical director convenes a multidisciplinary quality improvement team to address this issue using the Lean Six Sigma DMAIC (Define, Measure, Analyze, Improve, Control) framework. Arrange the following actions in the correct chronological sequence according to this methodology.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence follows the DMAIC framework: Define the problem, Measure baseline data, Analyze root causes, Improve the process, and Control to sustain gains.
The DMAIC methodology is a core component of Lean Six Sigma used for process improvement. It must follow a strict, sequential order: Define (establish the problem and goals), Measure (collect baseline performance data), Analyze (identify root causes using tools like Ishikawa diagrams), Improve (implement and pilot solutions), and Control (monitor metrics to sustain the gains).

Step-by-Step Solution

1
Identify the initial phase of the framework.
The Define phase (drafting the problem statement and goals) must occur first.
A quality improvement project cannot proceed effectively without a clearly defined scope and objective.
2
Determine the subsequent data gathering phase.
The Measure phase (extracting EHR data and quantifying frequencies) follows next.
Baseline data must be collected to understand the current state before analyzing why the system behaves the way it does.
3
Locate the phase where root causes are investigated.
The Analyze phase (constructing the Ishikawa diagram) is the third step.
Once data is reliably collected, the team determines the underlying causes of the process defects.
4
Identify the intervention phase.
The Improve phase (piloting the pre-admission phone call) is fourth.
Interventions are tested and implemented only after root causes are clearly understood.
5
Determine the final sustainability phase.
The Control phase (creating the monthly dashboard) concludes the sequence.
Monitoring ensures that the implemented improvements are sustained over time and that the system does not revert to the previous baseline.

Key Concept

Lean Six Sigma: DMAIC Methodology
Question 3887Question →

A medical epidemiologist at a national occupational health authority is investigating a suspected etiological link between prolonged exposure to a specific aerosolized solvent used in synthetic rubber manufacturing and the development of hepatic angiosarcoma. Hepatic angiosarcoma is an exceptionally rare malignancy, with an estimated incidence of less than 1 case per million person-years. Because a prospective cohort study would be economically and logistically impractical, the epidemiologist searches a national cancer registry and identifies 38 patients who received a confirmed diagnosis of hepatic angiosarcoma between 2015 and 2025. Which of the following study designs and analytical strategies is most appropriate to establish an association in this context?

Show answer & explanation

Answer: Select a group of individuals without hepatic angiosarcoma from the general population and compare the odds of prior solvent exposure between the two groups.

Answer

Select a group of individuals without hepatic angiosarcoma from the general population and compare the odds of prior solvent exposure between the two groups.
The correct approach describes a case-control study. When investigating an exceptionally rare disease, it is statistically and practically inefficient to use a cohort design, as an enormous number of people would need to be followed for years just to observe a few cases. A case-control study elegantly solves this by selecting patients who already have the outcome of interest (in this case, the 38 patients from the registry) and comparing them to a control group without the disease. Investigators can then retrospectively analyze and compare the odds of prior exposure to the suspected risk factor (the aerosolized solvent) between the two groups.

Step-by-Step Solution

1
Analyze the disease characteristics presented in the scenario.
The outcome (hepatic angiosarcoma) is explicitly described as an exceptionally rare condition (incidence less than 1 per million person-years).
Disease rarity is the primary determinant when selecting an efficient observational study design.
2
Evaluate the practical limitations of study designs for rare diseases.
Prospective cohort studies require massive sample sizes and long follow-up periods to capture enough incident cases of a rare disease, making them highly inefficient.
To achieve adequate statistical power, the design must efficiently aggregate rare outcomes.
3
Select the optimal epidemiological study design.
A case-control study is chosen.
By identifying subjects based on the presence of the disease (cases) and comparing them to those without the disease (controls), investigators can retrospectively assess past exposures and calculate an odds ratio.

Key Concept

Case-control studies are the optimal epidemiological design for investigating the etiology of rare diseases, allowing researchers to calculate an odds ratio by comparing past exposures between affected cases and unaffected controls.
Question 3888Question →

A 75-year-old man with a history of heart failure and osteoarthritis presents to the emergency department with a 3-day history of fever, productive cough, and acute confusion. Vital signs show a temperature of 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure of 85/5085/50 mm Hg, heart rate of 115115/min, and respiratory rate of 3232/min. Laboratory studies reveal a blood urea nitrogen (BUN) of 4040 mg/dL. He is diagnosed with severe community-acquired pneumonia. Over the subsequent weeks, his infection is successfully treated, but he experiences profound deconditioning. Prior to admission, he was entirely independent with his activities of daily living. Currently, he requires moderate assistance to transfer from a bed to a chair and tolerates a maximum of 4545 minutes of physical therapy daily. His long-term goal is to return to his baseline level of independent living in the community.

Arrange the following care settings in the most appropriate chronological sequence for this patient's complete transition of care, from initial emergency department disposition to final community recovery, based on standard risk stratification and functional assessment guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological transition pathway is: Medical Intensive Care Unit (MICU) → General Medical Ward → Skilled Nursing Facility (SNF) → Home with Home Health Agency (HHA) services → Outpatient Rehabilitation Clinic.
The correct chronological sequence is dictated by the patient's evolving clinical severity and functional capacity. First, his CURB-65 score of 55 mandates initial Medical Intensive Care Unit (MICU) admission. Second, following critical care stabilization, he must transition to a General Medical Ward to complete his acute hospitalization. Third, at the time of hospital discharge, his inability to tolerate 33 hours of daily therapy necessitates placement in a Skilled Nursing Facility (SNF) rather than an acute rehabilitation center. Fourth, as he improves and returns home, his initial 'homebound' status qualifies him for Home Health Agency (HHA) services. Finally, once he is no longer homebound, he completes his functional recovery in an Outpatient Rehabilitation Clinic.

Step-by-Step Solution

1
Calculate the CURB-65 score to determine the appropriate initial emergency department disposition.
The CURB-65 score is 55.
The patient meets all 5 criteria: Confusion (11 point), BUN >19> 19 mg/dL (11 point), Respiratory Rate ≥30\geq 30/min (11 point), Blood Pressure <90/60< 90/60 mm Hg (11 point), and Age ≥65\geq 65 years (11 point). A score of 4−54-5 indicates severe pneumonia requiring MICU admission.
2
Determine the appropriate step-down environment after critical illness stabilizes.
General Medical Ward.
Once hemodynamically stable in the MICU, patients require transition to a general medical ward for continued acute care observation and initiation of early mobilization before they are ready for discharge.
3
Assess functional capacity and physical therapy tolerance to select the post-acute discharge facility.
Skilled Nursing Facility (SNF).
The patient has severe deconditioning but only tolerates 4545 minutes of therapy per day. This makes him ineligible for an Acute Inpatient Rehabilitation Facility (IRF), which strictly requires tolerance of at least 33 hours of intensive therapy daily.
4
Determine the criteria for community-based transitional care once inpatient rehabilitation is complete.
Home with Home Health Agency (HHA) services.
After improving in the SNF, he can return home. However, his deconditioning means leaving the house will require a considerable and taxing effort, classifying him as 'homebound' and qualifying him for HHA services.
5
Identify the final care setting for long-term functional maintenance once the patient is no longer homebound.
Outpatient community-based rehabilitation.
Once the patient regains sufficient strength to travel into the community safely, he no longer meets the Medicare definition of 'homebound' and must transition to an outpatient clinic to fully restore his baseline.

Key Concept

Disposition transitions require strict adherence to objective criteria: CURB-65 for CAP admission triage, the 33-hour therapy rule for IRF vs. SNF placement, and 'homebound' status for HHA vs. outpatient services.
Estimated Time:2m 30s
Question 3889Question →

A 16-year-old girl is evaluated in the clinic for heavy menstrual bleeding. She reports that since menarche at age 12, her menstrual periods have consistently lasted 8 to 10 days, frequently requiring her to change pads every 2 hours on the heaviest days. She also recalls an episode of prolonged bleeding following a dental extraction two years ago. The patient takes no daily medications, though she occasionally uses ibuprofen for cramps. Family history is notable for a maternal aunt who required a blood transfusion after childbirth. Physical examination reveals normal vital signs, no joint deformities, and no petechiae or ecchymoses. The physician suspects von Willebrand disease (vWD) and plans to initiate a laboratory workup. Arrange the following tiers of laboratory testing in the most appropriate sequential diagnostic order, from initial screening to definitive disease subtyping.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of diagnostic testing is: 1) CBC, PT, and aPTT; 2) vWF antigen, vWF activity, and Factor VIII activity; 3) vWF multimer analysis.
The diagnostic evaluation of a suspected bleeding disorder must follow a stepwise, cost-effective algorithmic approach. The correct sequence begins with broad screening tests (CBC, PT, aPTT) to rule out common etiologies like thrombocytopenia. Once basic screening indicates a primary hemostatic defect without thrombocytopenia, the initial specific vWD panel (vWF antigen, vWF activity, and Factor VIII) is ordered to establish the diagnosis. Finally, specialized tests such as vWF multimer analysis are ordered only after confirming the diagnosis in order to determine the specific subtype, which critically dictates whether treatments like desmopressin (DDAVP) will be safe and effective.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation.
The presentation of severe menorrhagia and a history of prolonged bleeding after dental procedures strongly suggests an underlying bleeding diathesis, most likely von Willebrand disease.
Clinical history establishes the pre-test probability and directs the scope of the initial laboratory workup.
2
Determine the most appropriate initial laboratory screening.
Select complete blood count, PT, and aPTT as the first step.
Standard diagnostic algorithms require ruling out common causes of bleeding, such as profound thrombocytopenia or severe global coagulation defects, before ordering expensive specific factor assays.
3
Determine the appropriate confirmatory diagnostic panel.
Select vWF antigen, vWF activity (e.g., Ristocetin cofactor), and Factor VIII activity as the second step.
These tests comprise the initial specific vWD screening panel. They confirm the presence of von Willebrand disease and measure the quantitative or qualitative functional deficiency of the factors.
4
Select the specific subtyping test.
Select vWF multimer analysis as the final step.
Once the diagnosis is confirmed, multimer analysis differentiates the specific disease subtype (e.g., distinguishing Type 1 from Type 2 variants). This is essential because treatments like desmopressin (DDAVP) are effective in Type 1 but can be ineffective or contraindicated in certain Type 2 subtypes.

Key Concept

Stepwise diagnostic evaluation of von Willebrand disease
Question 3890Question →

A 54-year-old woman comes to the clinic due to persistent joint pain and morning stiffness. She was diagnosed with rheumatoid arthritis two years ago and has been taking oral methotrexate, but her symptoms remain poorly controlled. Physical examination shows active synovitis and effusion in the bilateral metacarpophalangeal and proximal interphalangeal joints. The physician plans to initiate a tumor necrosis factor (TNF) alpha inhibitor. Before starting the new medication, an interferon-gamma release assay is obtained and is positive. A chest radiograph shows no abnormalities, and she has no cough, night sweats, or weight loss. The physician decides to delay the biologic therapy and initiates a course of rifampin. The proposed biologic therapy increases the risk of disease reactivation in this patient by directly impairing which of the following immunologic processes?

Show answer & explanation

Answer: Maintenance of macrophage-rich organized cellular aggregates

Answer

Maintenance of macrophage-rich organized cellular aggregates
The correct answer identifies the maintenance of macrophage-rich organized cellular aggregates (granulomas). The patient's positive IGRA and asymptomatic presentation indicate latent tuberculosis infection (LTBI). In LTBI, Mycobacterium tuberculosis is contained within caseating granulomas in the lungs. Tumor necrosis factor-alpha (TNF-alpha), secreted primarily by macrophages and T cells, is a critical cytokine that sustains macrophage activation and maintains the architectural integrity of these granulomas. The use of a TNF-alpha inhibitor disrupts this delicate balance, leading to the dissolution of the granuloma and subsequent reactivation and dissemination of the mycobacteria. Consequently, patients must be screened for and treated for LTBI prior to starting TNF-alpha inhibitor therapy.

Step-by-Step Solution

1
Interpret the pre-treatment screening results.
The patient has a positive interferon-gamma release assay (IGRA) with a normal chest radiograph and no systemic symptoms, confirming a diagnosis of latent tuberculosis infection (LTBI).
Screening for latent tuberculosis is mandatory before initiating biologic therapies that suppress cell-mediated immunity.
2
Identify the pharmacologic target of the proposed therapy.
The planned medication is a TNF-alpha inhibitor.
Understanding the drug class allows correlation with its specific immunologic effects.
3
Correlate the mechanism of the drug with the underlying pathology of the infection.
TNF-alpha is essential for activating macrophages and maintaining the structural integrity of caseating granulomas. Inhibiting TNF-alpha will cause granuloma breakdown, leading to the reactivation of latent tuberculosis.
This explains the physiological basis for the absolute contraindication of starting TNF-alpha inhibitors prior to treating LTBI.

Key Concept

Tumor necrosis factor-alpha (TNF-alpha) is vital for the maintenance of granulomas in latent tuberculosis; administration of TNF-alpha inhibitors disrupts this immunologic process, predisposing patients to life-threatening reactivation of the disease.
Question 3891Question →

A 6464-year-old woman is evaluated in the oncology clinic to discuss systemic therapy for newly diagnosed metastatic colorectal cancer. Two weeks ago, she underwent a right hemicolectomy for an obstructing cecal mass. Intraoperative findings and subsequent imaging confirmed the presence of unresectable bilobar hepatic metastases. Pathology of the primary tumor demonstrated moderately differentiated adenocarcinoma. Comprehensive molecular profiling of the tumor tissue reveals a missense mutation in codon 1212 of the KRAS gene. The patient has no other significant past medical history and her Eastern Cooperative Oncology Group (ECOG) performance status is 00. The medical team plans to initiate a combination cytotoxic chemotherapy regimen. Based on the molecular pathology findings, the addition of a monoclonal antibody directed against which of the following targets is specifically contraindicated due to lack of therapeutic benefit?

Show answer & explanation

Answer: Epidermal growth factor receptor

Answer

Epidermal growth factor receptor
Epidermal growth factor receptor (EGFR) signaling is a critical driver of cellular proliferation in colorectal carcinoma. The KRAS gene encodes a small GTPase protein that functions directly downstream of EGFR in the RAS-RAF-MEK-ERK signaling cascade. When a patient has a KRAS mutation (most commonly in codons 12, 13, or 61), the resulting RAS protein remains locked in a constitutively active, GTP-bound state. This leads to continuous downstream signaling and tumor growth regardless of upstream receptor activation. Because the pathway is continuously activated downstream of the receptor, administering monoclonal antibodies that block the upstream Epidermal growth factor receptor (such as cetuximab or panitumumab) provides no therapeutic benefit. Consequently, anti-EGFR therapies are specifically contraindicated in patients with KRAS-mutated colorectal cancer.

Step-by-Step Solution

1
Analyze the patient's diagnosis and molecular profiling results.
The patient has metastatic colorectal cancer with a KRAS codon 12 mutation.
Identifying actionable molecular targets is required to predict therapeutic response and avoid ineffective treatments.
2
Determine the role of the KRAS mutation in tumor intracellular signaling.
Mutated KRAS protein remains in a constitutively active state, causing continuous activation of the downstream RAS-RAF-MEK-ERK pathway regardless of upstream receptor activity.
Understanding the precise location of the mutated protein within the cellular signaling cascade is necessary to anticipate mechanisms of pharmacologic resistance.
3
Identify the targeted therapy class that is contraindicated by this mechanism.
Monoclonal antibodies directed against the Epidermal growth factor receptor (EGFR) are contraindicated because blocking the upstream receptor fails to halt the downstream constitutive signaling driven by the KRAS mutation.
Evidence-based guidelines mandate KRAS testing before initiating anti-EGFR therapies to prevent the administration of ineffective and potentially toxic agents.

Key Concept

Patients with metastatic colorectal cancer harboring KRAS mutations are inherently resistant to anti-EGFR monoclonal antibodies (e.g., cetuximab, panitumumab) because the mutated RAS protein continuously drives cellular proliferation downstream, independent of upstream EGFR blockade.
Question 3892Question →

An emergency response team brings a 59-year-old male to the trauma bay due to the abrupt onset of excruciating pain between his shoulder blades. The patient describes the pain as a "ripping" sensation that started 45 minutes prior to arrival. His medical history includes long-standing hypertension and a severe allergic reaction to iodinated contrast dye five years ago that resulted in anaphylactic shock and required mechanical ventilation. Current vital signs include a heart rate of 112/min, a respiratory rate of 22/min, and blood pressure readings of 205/115 mm Hg in the right arm and 175/95 mm Hg in the left arm. A bedside electrocardiogram reveals sinus tachycardia with left ventricular hypertrophy but no acute ischemic changes. A portable chest radiograph shows a widened mediastinum. Which of the following is the most appropriate next imaging study to establish the diagnosis?

Show answer & explanation

Answer: Transesophageal echocardiography

Answer

Transesophageal echocardiography
The patient's clinical presentation of sudden-onset 'ripping' chest pain radiating to the back, asymmetric upper extremity blood pressures, and a widened mediastinum is classic for an acute aortic dissection. Rapid, definitive imaging is required to identify the intimal flap and determine whether the ascending aorta is involved (Type A, requiring emergency surgery) or solely the descending aorta (Type B, typically managed medically). The primary diagnostic modalities are computed tomography angiography (CTA), transesophageal echocardiography (TEE), and magnetic resonance angiography (MRA). CTA is usually the initial test of choice due to its speed and availability; however, it requires intravenous iodinated contrast. Because this patient has a history of severe anaphylaxis to iodine contrast, CTA is contraindicated. TEE is the best next step because it is highly sensitive and specific, avoids contrast administration, and can be performed quickly at the bedside in a potentially unstable patient.

Step-by-Step Solution

1
Analyze the clinical presentation to formulate a differential diagnosis.
The patient presents with sudden, ripping interscapular pain, asymmetric blood pressures, and a widened mediastinum on chest radiograph.
These findings are highly suggestive of an acute thoracic aortic dissection, an emergency requiring rapid diagnosis.
2
Evaluate the patient's specific medical history for contraindications to standard diagnostic testing.
The patient has a history of severe anaphylactic shock and mechanical ventilation due to iodinated contrast media.
Computed tomography angiography (CTA) is the standard first-line test but requires iodinated contrast, making it absolutely contraindicated here.
3
Select the most appropriate alternative imaging modality that balances diagnostic accuracy, speed, and patient safety.
Transesophageal echocardiography (TEE) is selected.
TEE provides high sensitivity and specificity for visualizing the aorta, can be done rapidly at the bedside, and avoids iodinated contrast entirely.

Key Concept

Appropriate selection of imaging for acute aortic dissection in patients with absolute contraindications to standard modalities.
Estimated Time:1m 0s
Question 3893Question →

A 4545-year-old man with a history of HIV infection presents to the emergency department due to a 44-week history of progressively worsening clumsiness of his right hand and difficulty walking. He admits to discontinuing his antiretroviral therapy two years ago. His vital signs are within normal limits. Neurological examination reveals right-sided hemiparesis, hyperreflexia in the right upper and lower extremities, and an unsteady, broad-based gait. His current CD4 +^+ lymphocyte count is 60 cells/mm360 \text{ cells/mm}^3. An MRI of the brain with and without gadolinium contrast is performed. The scan reveals several asymmetric, hyperintense lesions on T2-weighted and FLAIR sequences located in the subcortical white matter of the left frontal and parietal lobes. The lesions do not demonstrate contrast enhancement, and there is no evidence of perilesional edema or mass effect.

Which of the following is the most likely diagnosis based on these imaging findings?

Show answer & explanation

Answer: Progressive multifocal leukoencephalopathy

Answer

Progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy (PML) is a central nervous system demyelinating disease caused by the JC virus, predominantly affecting severely immunocompromised patients. The characteristic MRI findings are multiple, asymmetric, focal hyperintense lesions on T2-weighted and FLAIR imaging located in the subcortical white matter. Crucially, these lesions do not typically demonstrate contrast enhancement, nor do they produce significant perilesional edema or mass effect. These specific imaging characteristics accurately match the findings described in the patient, confirming the diagnosis.

Step-by-Step Solution

1
Evaluate the patient's immune status and symptom onset.
The patient has advanced, untreated HIV with a low CD4 count and subacute, asymmetric focal neurologic deficits.
Establishing the clinical context and time course helps narrow the differential for opportunistic CNS infections.
2
Analyze the specific findings on the brain MRI.
The MRI shows asymmetric, T2/FLAIR hyperintense subcortical white matter lesions lacking contrast enhancement, mass effect, or perilesional edema.
Accurate interpretation of the presence or absence of enhancement and mass effect is the critical differentiating factor among CNS lesions in immunocompromised states.
3
Correlate imaging features with the differential diagnosis.
The imaging findings specifically match Progressive multifocal leukoencephalopathy, ruling out conditions with typical enhancement or edema like toxoplasmosis and lymphoma.
Finalizing the diagnosis requires matching the distinct radiographic pattern to the correct pathophysiology.

Key Concept

Interpreting characteristic MRI findings of Progressive Multifocal Leukoencephalopathy (PML) to differentiate it from other central nervous system lesions in immunocompromised patients.
Question 3894Question →

An infectious disease specialist is reviewing the laboratory data of five adult patients referred to an ambulatory clinic for evaluation of potential liver disease. Vital signs are within normal limits for all patients. Reference ranges for the hepatic panel are as follows: AST 8−408-40 U/L, ALT 7−567-56 U/L, Total Bilirubin 0.1−1.20.1-1.2 mg/dL. Match each patient's comprehensive biochemical and serological laboratory profile to the most accurate diagnostic interpretation.

Click a left item, then click its matching right item

Items

Profile A: AST 1818 U/L, ALT 2222 U/L. Serology: HBsAg (-), Anti-HBs (+), Total Anti-HBc (-), Anti-HBc IgM (-)
Profile B: AST 2020 U/L, ALT 1919 U/L. Serology: HBsAg (-), Anti-HBs (+), Total Anti-HBc (+), Anti-HBc IgM (-)
Profile C: AST 850850 U/L, ALT 10501050 U/L, Total Bilirubin 4.24.2 mg/dL. Serology: HBsAg (+), Anti-HBs (-), Total Anti-HBc (+), Anti-HBc IgM (+)
Profile D: AST 450450 U/L, ALT 520520 U/L, Total Bilirubin 2.82.8 mg/dL. Serology: HBsAg (-), Anti-HBs (-), Total Anti-HBc (+), Anti-HBc IgM (+)
Profile E: AST 6565 U/L, ALT 7878 U/L, Total Bilirubin 1.01.0 mg/dL. Serology: HBsAg (+), Anti-HBs (-), Total Anti-HBc (+), Anti-HBc IgM (-)

Matches

Show answer & explanation

Answer

Profile A matches Vaccination; Profile B matches Resolved infection; Profile C matches Acute infection; Profile D matches the Window period; Profile E matches Chronic infection.
Each laboratory profile distinctly maps to a specific phase of Hepatitis B immunity or infection, driven by the presence or absence of specific surface and core antigens/antibodies over time, corroborated by the degree of hepatocellular injury (transaminase levels).

Step-by-Step Solution

1
Analyze the surface antigen (HBsAg) and surface antibody (Anti-HBs) status.
Positive HBsAg indicates current active viral presence (Profiles C and E). Positive Anti-HBs indicates immunity (Profiles A and B). Negative for both suggests the window period (Profile D).
These are the primary markers for active viral presence versus long-term immunity.
2
Evaluate the core antibodies (Total Anti-HBc and Anti-HBc IgM).
Positive Total Anti-HBc indicates natural viral exposure (Profiles B, C, D, E), differentiating them from vaccination (Profile A). Positive IgM indicates recent/acute exposure (Profiles C and D).
Core antibodies reliably distinguish isolated recombinant vaccination from natural whole-virus infection and separate acute from chronic states.
3
Correlate the serology findings with hepatic transaminases and bilirubin levels.
Marked elevations in AST/ALT align with an acute infection or the subsequent window period (Profiles C and D). Mild elevations align with chronic infection (Profile E). Normal levels align with established immunity (Profiles A and B).
Liver function tests reflect the degree of active hepatocellular injury, validating the timeline established by the serological markers.

Key Concept

Hepatitis B Serology Interpretation
Question 3895Question →

A 5454-year-old woman is brought to the emergency department for severe shortness of breath, dizziness, and chest tightness that has progressively worsened over the past 4848 hours. She was treated for a severe viral upper respiratory tract infection three weeks ago. On presentation, she appears anxious, diaphoretic, and pale. Vital signs show a temperature of 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure of 86/6686/66 mmHg, heart rate of 122122/min, and respiratory rate of 2424/min. The physician suspects cardiac tamponade as the primary cause of her hemodynamic instability. Based on this suspected diagnosis, which of the following physical examination findings are highly indicative of this specific condition? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: An inspiratory decline in systolic blood pressure of greater than 1010 mmHg; Jugular venous distention with a prominent xx descent and an absent yy descent

Answer

The highly indicative findings are an inspiratory decline in systolic blood pressure of greater than 10 mmHg (pulsus paradoxus) and jugular venous distention with an absent y descent.
Cardiac tamponade restricts cardiac filling throughout the entire diastolic period due to increased intrapericardial pressure. This leads to exaggerated ventricular interdependence, directly resulting in pulsus paradoxus (an inspiratory drop in systolic blood pressure >10>10 mmHg). Furthermore, because the high external pressure prevents the right ventricle from accepting blood rapidly during early diastole, the normal yy descent in the jugular venous pressure waveform is characteristically absent, while the xx descent (atrial relaxation) remains prominent.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient exhibits severe hypotension, tachycardia, and a distinctly narrow pulse pressure (86/6686/66 mmHg) following a recent viral illness.
Recognizing the transition from an isolated viral infection to obstructive shock is critical for anticipating the expected physical exam findings.
2
Identify the physiologic impact of cardiac tamponade on the systemic circulation.
High-pressure pericardial fluid compresses all heart chambers, limiting overall diastolic filling and creating exaggerated ventricular interdependence (where right ventricular expansion during inspiration directly compromises left ventricular filling).
This mechanism directly explains the manifestation of an abnormally large drop in systolic blood pressure during inspiration (pulsus paradoxus).
3
Determine the expected changes in the jugular venous pressure (JVP) waveform.
Because the heart is continuously compressed throughout the entire cardiac cycle, early rapid ventricular filling in diastole is prevented. Consequently, the normal yy descent (which represents the fall in right atrial pressure as blood flows into the right ventricle) is absent.
Differentiating JVP waveform abnormalities is a high-yield clinical skill required to distinguish cardiac tamponade from other causes of right heart failure, such as constrictive pericarditis.

Key Concept

The physical examination hallmarks of cardiac tamponade include pulsus paradoxus (due to exaggerated ventricular interdependence) and an absent yy descent on the JVP waveform (due to restricted early diastolic filling).
Question 3896Question →

A 62-year-old man is evaluated in the emergency department for persistent bleeding from a minor forearm laceration sustained 3 hours ago. He also reports recent episodes of epistaxis and easy bruising over the past week. He has a 30-year history of severe alcohol use disorder. Vital signs are within normal limits. Physical examination reveals scleral icterus, palmar erythema, shifting dullness on abdominal exam, and several ecchymoses on the lower extremities.

Laboratory results are as follows:

Laboratory TestResultReference Range
Hemoglobin10.4 g/dL10.4 \text{ g/dL}13.5−17.5 g/dL13.5 - 17.5 \text{ g/dL}
Platelets72,000/μL72,000/\mu \text{L}150,000−400,000/μL150,000 - 400,000/\mu \text{L}
Prothrombin time (PT)26 sec26 \text{ sec}11−15 sec11 - 15 \text{ sec}
Partial thromboplastin time (aPTT)54 sec54 \text{ sec}25−40 sec25 - 40 \text{ sec}
Fibrinogen110 mg/dL110 \text{ mg/dL}150−400 mg/dL150 - 400 \text{ mg/dL}
D-dimer950 ng/mL950 \text{ ng/mL}<500 ng/mL< 500 \text{ ng/mL}
Factor V activity25%25\%50%−150%50\% - 150\%
Factor VIII activity185%185\%50%−150%50\% - 150\%

Which of the following is the most likely etiology of this patient's bleeding diathesis?

Show answer & explanation

Answer: Hepatic synthetic dysfunction

Answer

Hepatic synthetic dysfunction
The correct answer is hepatic synthetic dysfunction. This patient has clinical signs of advanced cirrhosis and a complex coagulopathy characterized by thrombocytopenia, prolonged PT/aPTT, low fibrinogen, and elevated D-dimer. These findings overlap significantly with disseminated intravascular coagulation (DIC). The key distinguishing laboratory test is the Factor VIII level. The liver synthesizes almost all coagulation factors, including Factor V, but Factor VIII is produced by endothelial cells. In severe liver disease, hepatically synthesized factors fall, but Factor VIII remains normal or becomes elevated due to decreased hepatic clearance and systemic inflammation. In contrast, DIC is a consumptive process that depletes all coagulation factors, including Factor VIII. The patient's elevated Factor VIII activity and low Factor V activity definitively point to hepatic synthetic dysfunction.

Step-by-Step Solution

1
Analyze the clinical presentation and routine coagulation panel.
The patient has stigmata of chronic liver disease (scleral icterus, palmar erythema, ascites) and a laboratory profile showing pancytopenia, prolonged PT and aPTT, hypofibrinogenemia, and elevated D-dimer.
This establishes a broad differential diagnosis for systemic coagulopathy, primarily between advanced liver disease and disseminated intravascular coagulation (DIC).
2
Evaluate the specific coagulation factor assays (Factor V and Factor VIII).
Factor V activity is low (25%), while Factor VIII activity is markedly elevated (185%).
Specific factor levels help differentiate between reduced hepatic synthesis and systemic factor consumption.
3
Synthesize the laboratory data to confirm the etiology.
The hepatocytes synthesize all coagulation factors except Factor VIII, which is synthesized by endothelial cells. In severe liver disease, all hepatically synthesized factors (including Factor V) are low, but Factor VIII levels remain normal or become elevated (due to reduced hepatic clearance and endothelial stress).
If this were DIC, both Factor V and Factor VIII would be consumed and therefore low. The elevated Factor VIII firmly establishes hepatic synthetic dysfunction as the cause.

Key Concept

Differentiating coagulopathy of liver disease from disseminated intravascular coagulation (DIC) using Factor VIII activity.
Estimated Time:1m 30s
Question 3897Question →

A 31-year-old man presents to the outpatient clinic reporting a 4-month history of frequent, bulky, foul-smelling bowel movements, significant flatulence, and a 4-kg (8.8-lb) weight loss. He notes that the diarrhea does not resolve with fasting. He also complains of an intensely pruritic, blistering rash on his forearms and knees that has worsened over the past few weeks. His medical history is notable for recurrent sinusitis since childhood. Vital signs are within normal limits. Physical examination reveals conjunctival pallor and excoriated papules with occasional intact vesicles on the extensor surfaces of the upper and lower extremities.

Laboratory testing reveals:

Laboratory parameterResultReference range
Hemoglobin10.5 g/dL13.5–17.5 g/dL
Mean corpuscular volume76 fL80–100 fL
Total serum IgA4 mg/dL70–400 mg/dL
IgA anti-tissue transglutaminase2 U/mL<4< 4 U/mL (Negative)

Which of the following is the most appropriate next step in laboratory evaluation for this patient's underlying condition?

Show answer & explanation

Answer: IgG deamidated gliadin peptide antibody testing

Answer

IgG deamidated gliadin peptide antibody testing
The correct answer is IgG deamidated gliadin peptide antibody testing. This patient presents with classic signs of celiac disease, including chronic malabsorptive diarrhea and dermatitis herpetiformis. Celiac disease is strongly associated with selective IgA deficiency (seen in 2-3% of patients with celiac disease). The initial laboratory workup shows a profoundly low total serum IgA level. The standard screening test for celiac disease is the IgA anti-tissue transglutaminase (anti-tTG) antibody. However, in the setting of selective IgA deficiency, the IgA anti-tTG will predictably yield a false-negative result, as seen in this patient. Therefore, the most appropriate next step in laboratory evaluation is to order an IgG-based serologic test, such as IgG deamidated gliadin peptide (DGP) antibody or IgG anti-tTG antibody, which accurately detects the immune response in these patients.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The combination of malabsorptive diarrhea, weight loss, microcytic anemia, and dermatitis herpetiformis (pruritic vesicles on extensor surfaces) is highly characteristic of celiac disease.
Establishing the most likely clinical diagnosis guides the interpretation of the laboratory workup.
2
Interpret the initial laboratory results.
The total serum IgA is profoundly low (44 mg/dL), confirming selective IgA deficiency. The IgA anti-tissue transglutaminase (anti-tTG) is negative.
Identifying the total IgA level is critical to determining the validity of the specific IgA anti-tTG test.
3
Determine the limitation of the initial test.
In patients with selective IgA deficiency, all IgA-based serologic assays for celiac disease will be falsely negative.
Patients with IgA deficiency cannot produce the IgA autoantibodies typically measured in standard celiac screening.
4
Select the appropriate alternative diagnostic test.
An IgG-based celiac serology, such as the IgG deamidated gliadin peptide (DGP) antibody or IgG anti-tTG antibody, must be ordered.
IgG-based assays bypass the patient's inability to mount an IgA response, providing an accurate assessment for celiac disease.

Key Concept

Diagnostic evaluation of celiac disease in patients with concurrent selective IgA deficiency requires the use of IgG-based serologic testing.
Question 3898Question →

A 58-year-old man presents to the clinic for evaluation of progressive, diffuse muscle weakness and a dull, aching pain in his lower back, pelvis, and thighs that has worsened over the past six months. He reports difficulty climbing stairs and rising from low chairs. He was diagnosed with celiac disease three years ago but admits to frequently consuming gluten-containing foods due to lifestyle constraints. He has no history of fractures or significant trauma. Vital signs are within normal limits. Physical examination reveals mild tenderness to palpation over the lumbar spine and bilateral proximal muscle weakness in the lower extremities (4/5 strength).

Laboratory results are as follows:

TestResultReference Range
Calcium, total8.2 mg/dL8.6–10.3 mg/dL
Phosphorus2.1 mg/dL2.5–4.5 mg/dL
Alkaline phosphatase385 U/L40–120 U/L
Gamma-glutamyl transferase (GGT)28 U/L9–48 U/L
Parathyroid hormone, intact115 pg/mL15–65 pg/mL
Creatinine0.8 mg/dL0.7–1.3 mg/dL

Which of the following is the most likely diagnosis based on these clinical and laboratory findings?

Show answer & explanation

Answer: Osteomalacia

Answer

Osteomalacia
The correct answer is Osteomalacia. This patient's presentation of diffuse bone pain, proximal muscle weakness, and a history of poorly compliant celiac disease is highly suspicious for severe vitamin D deficiency leading to osteomalacia. The laboratory findings confirm this diagnosis through a specific multi-step pattern. First, the elevated alkaline phosphatase (ALP) is determined to be of bone origin rather than hepatic origin because the gamma-glutamyl transferase (GGT) is entirely normal. Second, the combination of low-normal calcium, low phosphorus, and significantly elevated parathyroid hormone (PTH) demonstrates secondary hyperparathyroidism. In the setting of celiac-induced malabsorption, the primary insult is vitamin D deficiency, which drastically reduces intestinal calcium and phosphorus absorption. The resulting transient hypocalcemia triggers the parathyroid glands to over-secrete PTH. The elevated PTH acts to normalize serum calcium at the expense of bone demineralization (raising bone ALP) while simultaneously causing renal phosphate wasting (lowering serum phosphorus). This profound defect in bone matrix mineralization manifests pathologically and clinically as osteomalacia.

Step-by-Step Solution

1
Determine the tissue origin of the elevated alkaline phosphatase.
The alkaline phosphatase is determined to be of bone origin.
The gamma-glutamyl transferase (GGT) is within normal limits, ruling out a hepatobiliary source for the elevated alkaline phosphatase.
2
Analyze the relationship between calcium, phosphorus, and parathyroid hormone (PTH).
The pattern indicates secondary hyperparathyroidism.
The low-normal total serum calcium has appropriately triggered a compensatory rise in parathyroid hormone secretion. The high PTH level then acts on the kidneys to increase phosphate excretion, resulting in hypophosphatemia.
3
Synthesize the laboratory pattern with the patient's medical history to establish the final diagnosis.
The underlying cause is severe vitamin D deficiency leading to osteomalacia.
The patient has poorly controlled celiac disease, which causes malabsorption of fat-soluble vitamins (A, D, E, K). The resulting profound vitamin D deficiency prevents adequate bone mineralization (osteomalacia), leading to the patient's progressive bone pain and proximal myopathy, supported by the classic laboratory profile of secondary hyperparathyroidism.

Key Concept

Secondary hyperparathyroidism due to vitamin D deficiency (osteomalacia)
Estimated Time:2m 0s
Question 3899Question →

During the evaluation of complex, undifferentiated clinical presentations, acquiring a targeted and nuanced social, dietary, and recreational history is paramount. Match each specific historical finding elicited during patient interviewing with the corresponding clinical diagnosis or syndrome it most strongly suggests.

Click a left item, then click its matching right item

Items

Frequent recreational inhalation of pressurized nitrous oxide from whipped cream chargers
Prolonged dietary ingestion of large quantities of raw egg whites for athletic training
Consumption of illicitly distilled ethanol ('moonshine') processed through salvaged automotive radiators
Recreational inhalation of volatile alkyl nitrites ('poppers') for sexual enhancement

Matches

Show answer & explanation

Answer

1 matches Subacute combined degeneration; 2 matches Biotin deficiency; 3 matches Lead toxicity; 4 matches Methemoglobinemia.
Each specific historical clue perfectly corresponds to a distinct pathophysiologic mechanism: nitrous oxide inactivates B12; avidin in raw eggs binds biotin; lead leaches from radiator solder into illicit alcohol; and alkyl nitrites oxidize hemoglobin.

Step-by-Step Solution

1
Analyze the history of nitrous oxide inhalation.
Identify nitrous oxide as a substance that inactivates vitamin B12.
Recognizing the mechanism (cobalt oxidation) directly links the recreational history to subacute combined degeneration.
2
Evaluate the dietary history of raw egg white consumption.
Identify the presence of avidin in raw egg whites.
Avidin binds biotin, linking the athletic diet to biotin deficiency.
3
Assess the origin of the homemade alcohol.
Identify automotive radiators as a source of heavy metal contamination.
Radiator solder contains lead, which leaches into the alcohol, pointing to lead toxicity rather than pure ethanol or methanol toxicity.
4
Evaluate the exposure to alkyl nitrites.
Identify nitrites as oxidizing agents.
Nitrites oxidize hemoglobin to methemoglobin, linking the recreational drug use to methemoglobinemia.

Key Concept

Identifying specific clinical syndromes based on precise, targeted questioning about obscure recreational, dietary, and social exposures.
Estimated Time:1m 30s
Question 3900Question →

A 28-year-old woman, G2P1, at 26 weeks gestation presents to the emergency department complaining of sudden-onset right-sided pleuritic chest pain, dyspnea, and a swollen right calf that began 6 hours ago. Her temperature is 37.1∘37.1^\circ C (98.8∘98.8^\circ F), blood pressure is 118/76118/76 mmHg, heart rate is 112112/min, and respiratory rate is 2222/min. Oxygen saturation is 96%96\% on room air. Physical examination reveals an enlarged, tender right calf with pitting edema. The physician highly suspects a pulmonary embolism. Assume that for each sequential imaging study performed, the results return as negative or indeterminate, necessitating progression to the next appropriate imaging modality to definitively evaluate for pulmonary embolism.

Arrange the following imaging modalities in the most appropriate step-wise sequence according to evidence-based diagnostic algorithms for pregnant patients.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Compression ultrasonography of the lower extremities, followed by Chest radiography, followed by Ventilation-perfusion (V/Q) scan, and finally Computed tomography pulmonary angiography (CTPA).
The correct diagnostic sequence for suspected pulmonary embolism in a pregnant patient with leg symptoms prioritizes identifying venous thromboembolism with zero radiation first. Therefore, compression ultrasonography of the lower extremity is step one. If negative, a chest radiograph (step two) is required to rule out alternative diagnoses and triage the next step. If the radiograph is normal, a V/Q scan (step three) is the preferred initial advanced imaging because it delivers lower radiation to maternal breast tissue compared to CTPA. Finally, if the V/Q scan is indeterminate, CTPA (step four) is utilized as the definitive study.

Step-by-Step Solution

1
Evaluate the symptomatic lower extremity for deep vein thrombosis.
Compression ultrasonography of the lower extremities is ordered.
If positive, it confirms venous thromboembolism and eliminates the need for thoracic imaging, protecting the fetus and maternal breast tissue from radiation.
2
Evaluate baseline thoracic anatomy if the initial ultrasound is negative.
Chest radiography is performed.
A chest radiograph is required to rule out other pathology (e.g., pneumothorax) and to guide the selection of the next advanced imaging study. A normal radiograph points toward a V/Q scan, while an abnormal one points toward CTPA.
3
Assess for pulmonary perfusion defects assuming a normal chest radiograph.
Ventilation-perfusion (V/Q) scan is obtained.
V/Q scanning is preferred over CTPA as the first-line advanced imaging in pregnancy with a normal chest radiograph because it exposes maternal breast tissue to substantially less radiation.
4
Obtain definitive anatomic vascular imaging if the V/Q scan is indeterminate.
Computed tomography pulmonary angiography (CTPA) is performed.
CTPA serves as the definitive test when prior low-radiation studies fail to yield a diagnostic result, resolving diagnostic uncertainty despite the higher radiation dose to maternal breast tissue.

Key Concept

The diagnostic algorithm for suspected pulmonary embolism in pregnancy prioritizes sequential testing to minimize maternal and fetal radiation exposure, utilizing leg ultrasound first for symptomatic limbs, followed by chest radiography to guide the choice between V/Q scanning and CTPA.

Alternative Method

If the initial chest radiograph is abnormal (e.g., shows an infiltrate or effusion), the sequence changes: the V/Q scan is bypassed entirely because it is highly likely to be non-diagnostic, and the algorithm proceeds directly to CT pulmonary angiography (CTPA).
Estimated Time:2m 0s
PreviousPage 195 / 237Next